Spots Global Cancer Trial Database for Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma
Official Title: Phase I/II Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma
Study ID: NCT03177668
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to examine tolerability, safety, and pharmacokinetics of YS110 intravenous administration in patients with malignant pleural mesothelioma and to preliminarily examine the anti-tumor effect of YS110.
Detailed Description:
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Site, Multiple Locations, , Japan
Contact Details
Name: Nobuo Kanai
Affiliation: Kissei Pharmaceutical Co., Ltd.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
